AGTX
Agentix Corp.
Key Financials
Operating Income
$-513251
↑ 31.1%
Revenue
$0
↓ 100.0%
Gross Profit
$0
↓ 100.0%
Net Income
$-567048
↑ 3.1%
EPS (Diluted)
$-0.01
0.0%
Shareholders' Equity
$-3104249.00
↓ 21.2%
Total Liabilities
$3.2M
↑ 20.2%
Total Assets
$100274.00
↓ 5.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 2/17/2026 | View on SEC |
| 10-Q | 11/20/2025 | View on SEC |
| 10-Q | 8/22/2025 | View on SEC |
| NT 10-Q | 8/15/2025 | View on SEC |
| 10-K | 7/16/2025 | View on SEC |
| NT 10-K | 7/1/2025 | View on SEC |
| 10-Q | 2/18/2025 | View on SEC |
| NT 10-Q | 2/14/2025 | View on SEC |
| 10-Q | 11/18/2024 | View on SEC |
| NT 10-Q | 11/14/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AGTX |
| Company Name | Agentix Corp. |
| CIK | 1603345 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | NV |
| Phone | 321-229-2014 |